regulatory
confidence high
sentiment negative
materiality 0.65
Streamex Corp. (STEX): Nasdaq/NYSE listing notice — BioSig Technologies receives Nasdaq bid-price deficiency notice; 180-day cure period until Oct 8, 2025
Streamex Corp.
- On April 11, 2025, Nasdaq notified BioSig that its common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 calendar days (until October 8, 2025) to regain compliance by closing at $1.00 or more for at least 10 consecutive days.
- If not cured by October 8, may seek an additional 180-day extension by meeting other listing standards and signaling intent to reverse split.
- Failure to regain compliance could lead to delisting from Nasdaq Capital Market; no immediate impact on trading.
- Stock continues to trade under symbol BSGM while the company addresses the deficiency.